Life Sciences Venture Capital Investing Falls 18% in Q3 2011 from Prior Quarter but Still Shows an Increase of 22% from Q3 2010,
NEW YORK, Nov. 3, 2011 /PRNewswire/ -- Following two quarters of growth, Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries, fell
Northern Trust Appoints Bob Morgan to Lead Alternatives Group for Hedge Fund and Private Equity Investments
CHICAGO--(BUSINESS WIRE)-- Northern Trust announced today that Robert P. Morgan has been named to lead a new unit, Northern Trust Alternatives Group, formed to develop and manage all alternative
Life Sciences Venture Capital Investing Leaps 37% in Q2 2011, According to the MoneyTree Report
NEW YORK, Aug. 11, 2011 /PRNewswire/ -- Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries, leapt 37 percent during the second
Industry Pioneer Hits 200th M&A Deal
Investors Affirm Need for Experienced Shareholder Representation SAN FRANCISCO--(BUSINESS WIRE)-- SRS | Shareholder Representative Services, the global expert in professionally managing post-closing
Life Sciences Venture Capital Investment Level Rebounds in Q1 2011 but Deal Volume Declines, According to the MoneyTree Report
NEW YORK, May 4, 2011 /PRNewswire/ -- Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries, recovered in terms of dollar
Xconomy Celebrates 65 Years of Venture Capital in America
Event Coincides with 2011 NVCA Annual Meeting and 150th Anniversary of MIT Exhibition CAMBRIDGE, Mass.--(BUSINESS WIRE)-- To celebrate the 65th anniversary of the venture capital industry and the
Business Leaders & Members of Congress Talk Jobs, Economy on Capitol Hill
-- NYSE Euronext Hosts Forum for Small & Mid-Sized Business Owners -- NEW YORK & WASHINGTON--(BUSINESS WIRE)-- NYSE Euronext (NYX), joined by the Senate Manufacturing Caucus and the National
NVCA Chair Kate Mitchell Delivers Pepperdine University Venture Capital Industry View, March 17
LOS ANGELES--(BUSINESS WIRE)-- Kate Mitchell, Managing Director with Scale Venture Partners and Chair of the National Venture Capital Association, will deliver the address “Venture Capital
Life Sciences Venture Capital Investment Slides in Q4 2010, According to the MoneyTree Report
NEW YORK, Feb. 10, 2011 /PRNewswire/ -- Venture capital (VC) funding in the Life Sciences sector, which includes the Biotechnology and Medical Device industries, fell steeply during the fourth
$221 Million Invested in Northeast Ohio Companies in 2010
Invested Dollars More Than Doubled Compared to 2009CLEVELAND, Jan. 21, 2011 /PRNewswire/ -- In 2010, 62 Northeast Ohio companies collectively raised $221 million from venture capitalists and angel
Latest Commentary